LIVIVO - Search results -

Search results

Result 1 - 10 of total 60

Search options

Article ; Online: Follow-up of COVID-19 recovered patients with mild disease.

Kashif, Alina / Chaudhry, Manahil / Fayyaz, Tehreem / Abdullah, Mohammad / Malik, Ayesha / Anwer, Javairia Manal Akmal / Inam, Syed Hashim Ali / Fatima, Tehreem / Iqbal, Noreena / Shoaib, Khadija

Scientific reports

2021 Volume 11, Issue 1, Page(s) 13414

Abstract: ... with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 ... the presence of prolonged symptoms months after recovery from mild COVID-19 disease, particularly ... COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having ...

Abstract	COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of the 11 studied symptoms were notably more prevalent amongst the female sample population. Our results validate the presence of prolonged symptoms months after recovery from mild COVID-19 disease, particularly in association with the female gender. Hence, proving the post-COVID syndrome is a recognizable diagnosis in the bigger context of the post-viral fatigue syndrome.
MeSH term(s)	Adult ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/pathology ; COVID-19/virology ; Comorbidity ; Fatigue/epidemiology ; Fatigue/etiology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; SARS-CoV-2/isolation & purification ; Severity of Illness Index ; Sex Factors ; Young Adult
Language	English
Publishing date	2021-06-28
Publishing country	England
Document type	Journal Article
ZDB-ID	2615211-3
ISSN	2045-2322 ; 2045-2322
ISSN (online)	2045-2322
ISSN	2045-2322
DOI	10.1038/s41598-021-92717-8
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Follow-up of COVID-19 recovered patients with mild disease

Alina Kashif / Manahil Chaudhry / Tehreem Fayyaz / Mohammad Abdullah / Ayesha Malik / Javairia Manal Akmal Anwer / Syed Hashim Ali Inam / Tehreem Fatima / Noreena Iqbal / Khadija Shoaib

Scientific Reports, Vol 11, Iss 1, Pp 1-

2021 Volume 5

Abstract: ... with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 ... the presence of prolonged symptoms months after recovery from mild COVID-19 disease, particularly ... Abstract COVID-19 may manifest as mild, moderate or severe disease with each grade of severity ...

Abstract	Abstract COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of the 11 studied symptoms were notably more prevalent amongst the female sample population. Our results validate the presence of prolonged symptoms months after recovery from mild COVID-19 disease, particularly in association with the female gender. Hence, proving the post-COVID syndrome is a recognizable diagnosis in the bigger context of the post-viral fatigue syndrome.
Keywords	Medicine ; R ; Science ; Q
Language	English
Publishing date	2021-06-01T00:00:00Z
Publisher	Nature Portfolio
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Lung function trajectories in mild COVID-19 with two-year follow-up.

Iversen, Katrine K / Ronit, Andreas / Ahlström, Magnus G / Nordestgaard, Børge G / Afzal, Shoaib / Benfield, Thomas

The Journal of infectious diseases

2024

Abstract: ... that mild COVID-19 infection affects lung function at time of infection with limited recovery two years ... changes in individuals with COVID-19 patients versus uninfected controls over two intervals: from pre ... Objective: To characterize lung function dynamics in individuals with mild COVID-19 from pre ...

Abstract	Objective: To characterize lung function dynamics in individuals with mild COVID-19 from pre-infection to two years post-infection. Methods: We re-invited participants two years after infection from our matched cohort study of the Copenhagen General Population who had initially been examined 5.4 months after infection. We repeated lung tests and questionnaires. Linear mixed models were used to estimate lung volume changes in individuals with COVID-19 patients versus uninfected controls over two intervals: from pre-infection to six months post-infection and six months post-infection to two years post-infection. Results: 52 individuals (48.6%) attended the two-year examination at median 1.9 years (IQR 1.8; 2.4) after COVID-19, all with mild infection. Individuals with COVID-19 had an adjusted excess decline in FEV1 of 13.0 mL per year (CI 23.5; 2.5), p=0.02 from prior infection to 6 months after infection compared to uninfected controls. From 6 to 24 months after infection, they had an excess decline of 7.5 mL per year (CI 25.6; 9.6), p=0.40. A similar pattern was observed for FVC. Participants had a mean increase in DLco of 3.33 (SD 7.97) between the 6- and 24-month examination. Conclusion: Our results indicate that mild COVID-19 infection affects lung function at time of infection with limited recovery two years after infection.
Language	English
Publishing date	2024-01-25
Publishing country	United States
Document type	Journal Article
ZDB-ID	3019-3
ISSN	1537-6613 ; 0022-1899
ISSN (online)	1537-6613
ISSN	0022-1899
DOI	10.1093/infdis/jiae037
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Uh II Zs.50: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 445: Show issues

Order via subito

Details ▾

Article ; Online: Longitudinal Echocardiographic Follow-Up of a Pediatric Multisystem Inflammatory Syndrome Cohort.

Ramamoorthy, Jaikumar Govindaswamy / Avinash, Anantharaj / Karunakar, Pediredla / Parale, Chinmay / Velayutham, Ramanathan / Sukumaran, Suresh Kumar / Balaguru, Sridhar / Parameswaran, Narayanan / M, Mugunthan / Dhodapkar, Rahul / Basu, Debdatta / Selvaraj, Raja / Satheesh, Santhosh / Biswal, Niranjan

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

2024 Volume 52, Issue 3, Page(s) 189–198

Abstract: ... at admission, 1.5 months, and 3 months. Coronavirus Disease 2019 (COVID-19) antibody titers were assessed ... parameters over a medium-term follow-up.: Methods: A cohort of 69 children was studied prospectively ... dysfunction was significantly associated with older age. During follow-up, severe LV dysfunction normalized ...

Title translation	Pediatrik Multisistem İnflamatuvar Sendrom Kohortunun Uzun Dönemli Ekokardiyografik İzlemi.
Abstract	Objective: Significant involvement of the cardiovascular system is known in multisystem inflammatory syndrome in children (MIS-C). This study aimed to examine the recovery of affected cardiovascular parameters over a medium-term follow-up. Methods: A cohort of 69 children was studied prospectively. Assessments of left ventricular (LV) function and coronary artery abnormalities (CAA) were conducted at admission, 1.5 months, and 3 months. Coronavirus Disease 2019 (COVID-19) antibody titers were assessed at these three time points. Echocardiographic and antibody parameters (rising/decreasing) were analyzed for correlation. Outcomes were assessed using logistic regression. Results: At admission, among the 78.2% of patients who were tested, 88.9% tested positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). A quarter of the patients had pericardial effusion, and half had valvulitis. Decreased ejection fraction, global circumferential strain (GCS), and global longitudinal strain (GLS) were seen in 54.4%, 68.6%, and 35.8% of patients, respectively. CAAs were observed in 27.78% of patients. Systolic dysfunction was significantly associated with older age. During follow-up, severe LV dysfunction normalized within 6-7 weeks, while mild to moderate dysfunction reached normalcy by two weeks. Both GCS and GLS reached normalcy within a median of two weeks. Diastolic parameters recovered by six weeks. Most small and moderate coronary aneurysms resolved, but a giant aneurysm in an infant remained large even after 15 months. Trends in antibodies and ejection fraction (EF) at three months were significantly correlated. Admission EF, GLS (at 6 weeks) and deceleration time (at 3 months) were significantly associated with intensive care unit (ICU) admission. The median segmental strain of the cohort remained low in certain segments at three months. Conclusion: Smaller CAAs resolve, whereas giant CAAs persist. EF and GLS are important predictors of Pediatric Intensive Care Unit (PICU) stay. The residual impairment of median segmental strain and persistent diastolic dysfunction at three months indicate the need for long-term follow-up.
MeSH term(s)	Infant ; Humans ; Child ; Follow-Up Studies ; Echocardiography ; COVID-19/diagnostic imaging ; COVID-19/complications ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome
Language	English
Publishing date	2024-04-04
Publishing country	Turkey
Document type	Journal Article
ZDB-ID	1215217-1
ISSN	1308-4488 ; 1016-5169
ISSN (online)	1308-4488
ISSN	1016-5169
DOI	10.5543/tkda.2023.60940
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4156: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Changes in Hematological and Hemorheological Parameters Following Mild COVID-19: A 4-Month Follow-Up Study.

Bros, Janina / Ibershoff, Lars / Zollmann, Emily / Zacher, Jonas / Tomschi, Fabian / Predel, Hans-Georg / Bloch, Wilhelm / Grau, Marijke

Hematology reports

2023 Volume 15, Issue 4, Page(s) 543–554

Abstract: ... hemorheological changes that were previously described for COVID-19 patients after the acute infection state are ... infection in COVID-19 patients and non-COVID control (T0) and 4 months later in COVID-19 patients (T1 ... still impaired at T1. The changes were thus more pronounced in male COVID-19 patients.: Conclusion ...

Abstract	Background: Coronavirus Disease 2019 (COVID-19) was described to affect red blood cells (RBC) in both severe and mild disease courses. The aim of this study was to investigate whether hematological and hemorheological changes that were previously described for COVID-19 patients after the acute infection state are still prominent after another 4 months to assess potential long-term effects. Methods: Hematological and RBC rheological parameters, including deformability and aggregation, were measured 41 days after infection in COVID-19 patients and non-COVID control (T0) and 4 months later in COVID-19 patients (T1). Results: The data confirm alterations in hematological parameters, mainly related to cell volume and hemoglobin concentration, but also reduced deformability and increased aggregation at T0 compared to control. While RBC deformability seems to have recovered, hemoglobin-related parameters and RBC aggregation were still impaired at T1. The changes were thus more pronounced in male COVID-19 patients. Conclusion: COVID-19-related changes of the RBC partly consist of several months and might be related to persistent symptoms reported by many COVID-19 patients.
Language	English
Publishing date	2023-10-10
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2586645-X
ISSN	2038-8330 ; 2038-8322
ISSN (online)	2038-8330
ISSN	2038-8322
DOI	10.3390/hematolrep15040057
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Six-month follow-up after recovery of COVID-19 Delta variant survivors

Huang, Jianliang / Lin, Ruikai / Bai, Na / Su, Zhongrui / Zhu, Mingxin / Li, Han / Chai, Conghai / Xia, Mingkai / Shu, Ziwei / Qiu, Zhaowen / Lei, Mingsheng

Frontiers in medicine

2023 Volume 10, Page(s) 1103559

Abstract: ... questionnaire results, and lung CT scans (at both discharge and 6-month follow-up) from 41 COVID-19 Delta ... up data of COVID-19 Delta variant survivors, evaluate and summarize the recovery and prognosis, and ... with those of the original COVID-19 for further comparison.: Results: The participants include 13 males (31.7%) and 28 ...

Abstract	Purpose: Using computer-aided diagnosis (CAD) methods to analyze the discharge and 6-month follow-up data of COVID-19 Delta variant survivors, evaluate and summarize the recovery and prognosis, and improve people's awareness of this disease. Methods: This study collected clinical data, SGRQ questionnaire results, and lung CT scans (at both discharge and 6-month follow-up) from 41 COVID-19 Delta variant survivors. Two senior radiologists evaluated the CT scans before in-depth analysis. Deep lung parenchyma enhancing (DLPE) method was used to accurately segment conventional lesions and sub-visual lesions in CT images, and then quantitatively analyze lung injury and recovery. Patient recovery was also measured using the SGRQ questionnaire. The follow-up examination results from this study were combined with those of the original COVID-19 for further comparison. Results: The participants include 13 males (31.7%) and 28 females (68.3%), with an average age of 42.2 ± 17.7 years and an average BMI of 25.2 ± 4.4 kg/m Conclusion: The ground-glass opacity of survivors had dissipated when they were discharged from hospital, and a little fibrosis was seen in CT after 6-month, mainly manifested as irregular lines, punctuate calcification and nodules. After DLPE and quantitative calculations, we found that the degree of fibrosis in the lungs of most survivors was mild, which basically did not affect lung function. However, there are a small number of patients with unabsorbed or increased fibrosis. Survivors mainly had non-pulmonary sequelae such as impaired sleep quality and memory decline. Pulmonary prognosis of Delta variant patients was better than original COVID-19, with fewer and milder sequelae.
Language	English
Publishing date	2023-02-02
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2775999-4
ISSN	2296-858X
ISSN	2296-858X
DOI	10.3389/fmed.2023.1103559
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: The Characteristics and Follow-Up of SARS-CoV-2 Infection in Pediatric Oncology Patients.

Alkharouby, Raghad / Aljehani, Noura / Alsubaie, Nasser / Alqarni, Anas / Hariri, Mohammed / Elimam, Naglla / AlhajHussein, Baraa / AlAzmi, Aeshah A

Cureus

2023 Volume 15, Issue 9, Page(s) e46149

Abstract: ... demonstrated that pediatric cancer patients with SARS-CoV-2 infection have a mild to moderate course of COVID ... experienced treatment interruptions reaching up to four weeks caused by COVID-19. ... in a delay in cancer treatment delivery of up to four weeks in 42.2% of patients. Conclusion Our data ...

Abstract	Introduction Clinical data about the first and second most prominent waves of SARS-CoV-2 among pediatric cancer patients were inconsistent. This study aims to retrospectively report the clinical characteristics and outcomes of SARS-CoV-2 infection in pediatric oncology patients. Methods This is an observational, retrospective study conducted in a tertiary care oncology center from March 2020 to May 2022. We reviewed the prevalence, severity of symptoms, and duration of positivity in relation to blood count laboratory data and mortality with a follow-up of 30 days post-infection for SARS-CoV-2. Results A total of 396 PCR tests were performed on 342 pediatric cancer patients. The overall rate of SARS-CoV-2 positivity was 43.1% (2.7% in the first wave and 95.4% in the second wave). Among 342 screened pediatric cancer patients, 72 patients had confirmed SARS-CoV-2 positivity in 92 different episodes. Nearly 59% had a mild or moderate infection, with fever and cough as the predominant presentations. The mean duration of positivity was 18.4±7.76 days. Comparing the laboratory values before and after acquiring the COVID-19 infection, only monocytes, hemoglobin, hematocrit, and platelets were statistically significantly affected, with P-values of 0.002, 0.03, 0.02, and 0.01, respectively. More than 18% of patients had grade 3 to 4 neutropenia (absolute neutrophil count=0.39±0.35) before COVID-19 infection and remained neutropenic throughout the disease, regardless of symptom severity. The mean recovery time was 13.67±8 days, which resulted in a delay in cancer treatment delivery of up to four weeks in 42.2% of patients. Conclusion Our data demonstrated that pediatric cancer patients with SARS-CoV-2 infection have a mild to moderate course of COVID-19 disease, with the majority being symptomatic, yet a great portion of our study population experienced treatment interruptions reaching up to four weeks caused by COVID-19.
Language	English
Publishing date	2023-09-28
Publishing country	United States
Document type	Journal Article
ZDB-ID	2747273-5
ISSN	2168-8184
ISSN	2168-8184
DOI	10.7759/cureus.46149
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Long-term follow-up of cardiac magnetic resonance imaging in myocarditis following messenger ribonucleic acid COVID-19 vaccination: a case report.

Kittichokechai, Pakaparn / Seripanu, Panupong / Laksomya, Thanakorn

European heart journal. Case reports

2023 Volume 7, Issue 5, Page(s) ytad245

Abstract: ... chest pain following the second dose of the Pfizer-BioNTech COVID-19 vaccine with long-term follow-up ... COVID-19 vaccination seem to be mild with fast clinical recovery. Nevertheless, the complete resolution ... follow-up and larger studies are needed to determine the complete resolution of the disease. ...

Abstract	Background: Presently, the association between myocarditis and messenger ribonucleic acid (mRNA) COVID-19 vaccination is well established. From the most current data, cases of myocarditis following COVID-19 vaccination seem to be mild with fast clinical recovery. Nevertheless, the complete resolution of the inflammatory process is still unclear. Case summary: We report the case of a 13-year-old boy who developed chest pain following the second dose of the Pfizer-BioNTech COVID-19 vaccine with long-term follow-up of cardiac magnetic resonance (CMR) imaging. An electrocardiogram (ECG) revealed progressively ST-segment elevation on the 2nd day of admission with a rapid improvement within 3 hours where only mild ST-segment elevation remained. The peak level of high-sensitivity cardiac troponin T was 1546 ng/L with rapid reduction. Echocardiogram revealed depressed left ventricular septal wall motion. CMR mapping techniques showed myocardial oedema with an increase in native T1 and extracellular volume (ECV). On the other hand, T1-weighted and T2-weighted images and late gadolinium enhancement (LGE) did not detect inflammation. The patient's symptoms were relieved by oral ibuprofen. After 2 weeks, ECG and echocardiogram were unremarkable. However, the inflammation process was still present based on the CMR by mapping technique. During the 6-month follow-up, CMR returned to normal. Discussion: In our case, the subtle myocardial inflammation was diagnosed by mapping technique with only a T1-based marker according to the updated Lake Louise Criteria and the inflammation of the myocardium returned to normal within 6 months after the onset of the disease. Further follow-up and larger studies are needed to determine the complete resolution of the disease.
Language	English
Publishing date	2023-05-18
Publishing country	England
Document type	Case Reports
ISSN	2514-2119
ISSN (online)	2514-2119
DOI	10.1093/ehjcr/ytad245
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Follow-up care after COVID-19 and its related concerns.

Radvan, Martin / Bartečků, Elis / Sýkorová, Ubica / Pařízková, Radana / Richter, Svatopluk / Kameník, Martin / Koc, Lumír / Kala, Petr

Vnitrni lekarstvi

2021 Volume 67, Issue 1, Page(s) 30–36

Abstract: Coronavirus disease 2019 (COVID-19) is an infectious disease caused ... some of the symptoms persist for weeks and months. Post-COVID-19 syndrome is a multisystem disease with overlapping ... of the patients recover within one or two weeks. However, in approximately 5-10 % of the patients ...

Title translation	Následná péče po prodělaném covidu-19 a její úskalí.
Abstract	Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Overall COVID-19-related rates of mortality are low; deaths usually occur in patients older than 60 and those suffering from serious chronic diseases. Most of the patients recover within one or two weeks. However, in approximately 5-10 % of the patients some of the symptoms persist for weeks and months. Post-COVID-19 syndrome is a multisystem disease with overlapping symptoms and may occur even in patients who were relatively mildly affected during the acute phase of the disease. Evaluating the number of patients with or after the novel coronavirus infection in the Czech Republic, it can be estimated that in the next months there will be about 50,000 new patients suffering from long-COVID-19 requiring attention of general practitioners in the least, and, in all probability, also of other medical specialists. A thorough knowledge of the syndrome and efficient ideally evidence-based guidelines have to be formulated to combat the adverse impact of the pandemic.
MeSH term(s)	Aftercare ; COVID-19 ; Czech Republic ; Humans ; Pandemics ; SARS-CoV-2
Language	English
Publishing date	2021-02-22
Publishing country	Czech Republic
Document type	Journal Article
ZDB-ID	138213-5
ISSN	1801-7592 ; 0042-773X
ISSN (online)	1801-7592
ISSN	0042-773X
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 327: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 526: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Psychophysical assessment of olfactory and gustatory function in post-mild COVID-19 patients: A matched case-control study with 2-year follow-up.

Boscolo-Rizzo, Paolo / Hummel, Thomas / Invitto, Sara / Spinato, Giacomo / Tomasoni, Michele / Emanuelli, Enzo / Tofanelli, Margherita / Cavicchia, Angelo / Grill, Vittorio / Vaira, Luigi Angelo / Lechien, Jerome R / Borsetto, Daniele / Polesel, Jerry / Dibattista, Michele / Menini, Anna / Hopkins, Claire / Tirelli, Giancarlo

International forum of allergy & rhinology

2023 Volume 13, Issue 10, Page(s) 1864–1875

Abstract: ... of chemosensory dysfunction in the no-coronavirus disease 2019 (COVID-19) population.: Method: This is ... 11.8%; 95% CI, -24.2% to 0.6%; p = 0.098). Subjects with prior COVID-19 were more likely ... smell/taste dysfunction more than 1 year after COVID-19, cases still exhibited a significant excess ...

Abstract	Background: The aim of this study was to psychophysically evaluate the prevalence of smell and taste dysfunction 2 years after mildly symptomatic severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection compared to that observed at 1-year follow-up and while considering the background of chemosensory dysfunction in the no-coronavirus disease 2019 (COVID-19) population. Method: This is a prospective case-control study on 93 patients with polymerase chain reaction (PCR)-positive SARS-CoV-2 infection and 93 matched controls. Self-reported olfactory and gustatory dysfunction was assessed by 22-item Sino-Nasal-Outcome Test (SNOT-22), item "Sense of smell or taste." Psychophysical orthonasal and retronasal olfactory function and gustatory performance were estimated using the extended Sniffin' Sticks test battery, 20 powdered tasteless aromas, and taste strips test, respectively. Nasal trigeminal sensitivity was assessed by sniffing a 70% solution of acetic acid. Results: The two psychophysical assessments of chemosensory function took place after a median of 409 days (range, 366-461 days) and 765 days (range, 739-800 days) from the first SARS-CoV-2-positive swab, respectively. At 2-year follow-up, cases exhibited a decrease in the prevalence of olfactory (27.9% vs. 42.0%; absolute difference, -14.0%; 95% confidence interval [CI], -21.8% to -2.6%; p = 0.016) and gustatory dysfunction (14.0% vs. 25.8%; absolute difference, -11.8%; 95% CI, -24.2% to 0.6%; p = 0.098). Subjects with prior COVID-19 were more likely than controls to have an olfactory dysfunction (27.9% vs. 10.8 %; absolute difference, 17.2%; 95% CI, 5.2% to 28.8%) but not gustatory dysfunction (14.0% vs. 9.7%; absolute difference, 4.3%; 95% CI, -5.8% to 14.4% p = 0.496) still 2 years after the infection. Overall, 3.2% of cases were still anosmic 2 years after the infection. Conclusions: Although a proportion of subjects recovered from long-lasting smell/taste dysfunction more than 1 year after COVID-19, cases still exhibited a significant excess of olfactory dysfunction 2 years after SARS-CoV-2 infection when compared to matched controls.
MeSH term(s)	Humans ; COVID-19/diagnosis ; COVID-19/epidemiology ; Smell ; SARS-CoV-2 ; Case-Control Studies ; Follow-Up Studies ; Olfaction Disorders/diagnosis ; Olfaction Disorders/epidemiology ; Taste Disorders/diagnosis ; Taste Disorders/epidemiology
Language	English
Publishing date	2023-03-15
Publishing country	United States
Document type	Journal Article
ZDB-ID	2625826-2
ISSN	2042-6984 ; 2042-6976
ISSN (online)	2042-6984
ISSN	2042-6976
DOI	10.1002/alr.23148
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 6927: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito